These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 12062953)

  • 21. Standard practice for cell sorting in a BSL-3 facility.
    Perfetto SP; Ambrozak DR; Nguyen R; Roederer M; Koup RA; Holmes KL
    Methods Mol Biol; 2011; 699():449-69. PubMed ID: 21116997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biosafety labs. The architect behind the new fortresses of science.
    Enserink M
    Science; 2003 Feb; 299(5608):812-5. PubMed ID: 12574599
    [No Abstract]   [Full Text] [Related]  

  • 23. Infectious diseases. New biodefense splurge creates hotbeds, shatters dreams.
    Enserink M
    Science; 2003 Oct; 302(5643):206-7. PubMed ID: 14551405
    [No Abstract]   [Full Text] [Related]  

  • 24. Rapid deployment of a mobile biosafety level-3 laboratory in Sierra Leone during the 2014 Ebola virus epidemic.
    Zhang Y; Gong Y; Wang C; Liu W; Wang Z; Xia Z; Bu Z; Lu H; Sun Y; Zhang X; Cao Y; Yang F; Su H; Hu Y; Deng Y; Zhou B; Zhao Z; Fu Y; Kargbo D; Dafae F; Kargbo B; Kanu A; Liu L; Qian J; Guo Z
    PLoS Negl Trop Dis; 2017 May; 11(5):e0005622. PubMed ID: 28505171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparing a community hospital to manage work-related exposures to infectious agents in BioSafety level 3 and 4 laboratories.
    Risi GF; Bloom ME; Hoe NP; Arminio T; Carlson P; Powers T; Feldmann H; Wilson D
    Emerg Infect Dis; 2010 Mar; 16(3):373-8. PubMed ID: 20202409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biosafety Level 4 Laboratory User Training Program, China.
    Xia H; Huang Y; Ma H; Liu B; Xie W; Song D; Yuan Z
    Emerg Infect Dis; 2019 May; 25(5):. PubMed ID: 31002302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The contribution of the European high containment laboratories during the 2014-2015 Ebola Virus Disease emergency.
    Nisii C; Vincenti D; Fusco FM; Schmidt-Chanasit J; Carbonnelle C; Raoul H; Eickmann M; Hewson R; Brave A; Nuncio S; Sanchez-Seco MP; Palyi B; Kis Z; Zange S; Nitsche A; Kurth A; Strasser M; Capobianchi MR; Ozin A; Guglielmetti P; Menel-Lemos C; Jacob D; Grunow R; Ippolito G; Di Caro A
    Clin Microbiol Infect; 2017 Feb; 23(2):58-60. PubMed ID: 27404371
    [No Abstract]   [Full Text] [Related]  

  • 28. Biosafety Professionals: A Role in the Pandemic Response Team.
    Warmbrod KL; Cole J; Sharkey CM; Sengupta A; Connell N; Casagrande R; Delarosa P
    Health Secur; 2021; 19(4):454-458. PubMed ID: 34415789
    [No Abstract]   [Full Text] [Related]  

  • 29. Risk-Based Reboot: New WHO Guidance for Laboratory Biosafety.
    Albtoush N; Noguez JH
    Clin Chem; 2018 Oct; 64(10):1544-1545. PubMed ID: 32100859
    [No Abstract]   [Full Text] [Related]  

  • 30. Hot zones.
    Fox CH
    Science; 1999 Apr; 284(5412):262-3. PubMed ID: 10232973
    [No Abstract]   [Full Text] [Related]  

  • 31. Moving on up: upgrading from an ABSL2 to ABSL3 facility.
    Hitt ND
    Lab Anim (NY); 2004 Nov; 33(10):30-4. PubMed ID: 15514654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resolving public conflict in site selection process-a risk communication approach.
    Ishizaka K; Tanaka M
    Waste Manag; 2003; 23(5):385-96. PubMed ID: 12893010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The global proliferation of high-containment biological laboratories: understanding the phenomenon and its implications.
    Peters A
    Rev Sci Tech; 2018 Dec; 37(3):857-883. PubMed ID: 30964462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Key challenges and concepts in health risk communication: perspectives of agency practitioners.
    Tinker TL; Zook E; Chapel TJ
    J Public Health Manag Pract; 2001 Jan; 7(1):67-75. PubMed ID: 11141625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biocontainment laboratory risk assessment: perspectives and considerations.
    Patterson A; Fennington K; Bayha R; Wax D; Hirschberg R; Boyd N; Kurilla M
    Pathog Dis; 2014 Jul; 71(2):102-8. PubMed ID: 24591404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An evaluation of the role and effectiveness of institutional biosafety committees in providing oversight and security at biocontainment laboratories.
    Race MS; Hammond E
    Biosecur Bioterror; 2008 Mar; 6(1):19-35. PubMed ID: 18386970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancing laboratory biosafety management: a comprehensive strategy from theory to practice.
    Tang Q; Yan F; Yuan L; Tang Y; Chen H; Sun Y; Yang M; Song G
    Front Public Health; 2024; 12():1439051. PubMed ID: 39371211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biosafety considerations in laboratory design.
    Mortland KK; Mortland DB
    Clin Leadersh Manag Rev; 2003; 17(3):175-7. PubMed ID: 12813961
    [No Abstract]   [Full Text] [Related]  

  • 39. Facility design considerations for select agent animal research.
    Frasier D; Talka J
    ILAR J; 2005; 46(1):23-33. PubMed ID: 15644561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biodefense facilities. Suit targets two DOE labs.
    Malakoff D
    Science; 2003 Aug; 301(5637):1168-9. PubMed ID: 12947171
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.